Tandem Investment Advisors Inc. lowered its position in shares of Genpact Limited (NYSE:G – Free Report) by 3.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,821,933 shares of the business services provider’s stock after selling 114,261 shares during the period. Genpact makes up approximately 4.9% of Tandem Investment Advisors Inc.’s portfolio, making the stock its 3rd largest position. Tandem Investment Advisors Inc.’s holdings in Genpact were worth $132,010,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in G. Clearstead Advisors LLC increased its holdings in shares of Genpact by 410.0% in the 4th quarter. Clearstead Advisors LLC now owns 5,483 shares of the business services provider’s stock worth $256,000 after purchasing an additional 4,408 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in Genpact by 565.4% in the 4th quarter. Hantz Financial Services Inc. now owns 2,615 shares of the business services provider’s stock worth $122,000 after buying an additional 2,222 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in Genpact by 46.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 7,072 shares of the business services provider’s stock worth $331,000 after buying an additional 2,244 shares during the last quarter. LSV Asset Management lifted its stake in Genpact by 15.1% during the 4th quarter. LSV Asset Management now owns 2,467,612 shares of the business services provider’s stock valued at $115,435,000 after acquiring an additional 324,345 shares during the period. Finally, Evoke Wealth LLC purchased a new stake in shares of Genpact during the 4th quarter valued at about $242,000. 96.03% of the stock is owned by institutional investors.
Insider Activity at Genpact
In related news, CEO Balkrishan Kalra sold 2,800 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total transaction of $114,156.00. Following the completion of the transaction, the chief executive officer directly owned 525,007 shares of the company’s stock, valued at approximately $21,404,535.39. This represents a 0.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.58% of the company’s stock.
Genpact Trading Down 0.1%
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings results on Tuesday, March 31st. The business services provider reported $0.98 earnings per share (EPS) for the quarter. The company had revenue of $1.30 billion for the quarter. Genpact had a net margin of 11.04% and a return on equity of 22.70%. On average, equities analysts predict that Genpact Limited will post 3.64 earnings per share for the current fiscal year.
Genpact Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be given a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Wednesday, June 10th. Genpact’s payout ratio is currently 23.01%.
Analysts Set New Price Targets
Several brokerages recently commented on G. Citigroup cut their price objective on Genpact from $43.00 to $35.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Wall Street Zen cut shares of Genpact from a “buy” rating to a “hold” rating in a research note on Saturday, March 14th. Mizuho cut their target price on shares of Genpact from $49.00 to $39.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Susquehanna dropped their price target on shares of Genpact from $42.00 to $37.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a report on Friday, May 8th. One investment analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $43.29.
Genpact Profile
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
See Also
- Five stocks we like better than Genpact
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
